Comcast Corp. (NASDAQ: CMCSA) has reported a sharp increase in adjusted earnings for the second quarter of 2023 when the telecommunications company’s revenues rose modestly.
Total revenues moved up 2% annually to $30.5 billion in the June quarter. Revenues of the Connectivity & Platforms segment remained broadly unchanged, while Content & Experiences revenue moved up 4%.
Adjusted earnings increased 12% year-over-year to $1.13 per share during the three-month period. Net income was $4.25 billion or $1.02 per share, compared to $3.40 billion or $0.76 per share in the prior-year quarter.
The consistent investments we’ve been making in our growth businesses continue to generate strong results and position us extremely well both now and into the future. Second quarter operational and financial performance was excellent and included a double-digit increase in Adjusted EPS and significant free cash flow generation,” said Brian Roberts, Comcast’s CEO.
Prior Performance
_________________________________________________________________________________________________________________
Stocks you may like:
International Business Machines Corp. (IBM) Stock
_________________________________________________________________________________________________________________
Most Popular
Nike (NKE) looks set to beat hurdles and build a brighter future
Nike, Inc. (NYSE: NKE) has long been ruling the sportswear market but the company had its share of problems when headwinds like the pandemic and economic slowdown hit the business
Electronic Arts (EA): A few points to keep in mind if you have an eye on this gaming company
Shares of Electronic Arts Inc. (NASDAQ: EA) stayed green on Friday. The stock has dropped 7% over the past three months. The video game industry has been facing challenges as
Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) is a pharma company focused on identifying, developing, and commercializing therapeutics for men's health issues. It operates mainly through the business segments of Prescription Medications
